Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 4 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3329.82 | 245 / 245 | 100% | 43.50 | 502 / 502 |
thymus | 100% | 3590.77 | 653 / 653 | 100% | 51.80 | 605 / 605 |
brain | 100% | 3654.40 | 2641 / 2642 | 100% | 54.96 | 705 / 705 |
skin | 100% | 2192.67 | 1808 / 1809 | 100% | 48.08 | 472 / 472 |
uterus | 100% | 2895.31 | 170 / 170 | 100% | 33.71 | 458 / 459 |
kidney | 100% | 4209.36 | 89 / 89 | 100% | 40.84 | 898 / 901 |
adrenal gland | 100% | 3760.73 | 258 / 258 | 100% | 45.39 | 229 / 230 |
pancreas | 100% | 1799.32 | 328 / 328 | 99% | 29.37 | 177 / 178 |
intestine | 100% | 2712.08 | 966 / 966 | 99% | 27.48 | 524 / 527 |
esophagus | 100% | 2399.84 | 1444 / 1445 | 99% | 31.56 | 182 / 183 |
breast | 100% | 2704.98 | 459 / 459 | 99% | 38.55 | 1109 / 1118 |
stomach | 100% | 2474.84 | 359 / 359 | 99% | 26.96 | 283 / 286 |
lung | 100% | 2238.38 | 577 / 578 | 99% | 29.59 | 1144 / 1155 |
ovary | 100% | 3030.94 | 180 / 180 | 98% | 27.66 | 422 / 430 |
liver | 100% | 1547.62 | 225 / 226 | 98% | 24.66 | 398 / 406 |
bladder | 100% | 2641.19 | 21 / 21 | 97% | 26.08 | 491 / 504 |
adipose | 100% | 2408.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 55.99 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.55 | 29 / 29 |
spleen | 100% | 3500.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.08 | 1 / 1 |
heart | 100% | 1878.90 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 2225.23 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2462.15 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1505.09 | 875 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006886 | Biological process | intracellular protein transport |
GO_1902017 | Biological process | regulation of cilium assembly |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | TBC1D13 |
Protein name | TBC1 domain family member 13 |
Synonyms | |
Description | FUNCTION: Acts as a GTPase-activating protein for RAB35. Together with RAB35 may be involved in regulation of insulin-induced glucose transporter SLC2A4/GLUT4 translocation to the plasma membrane in adipocytes. . |
Accessions | Q9NVG8 ENST00000372648.10 [Q9NVG8-1] ENST00000223865.8 [Q9NVG8-2] |